Nutan Pharmacy Limited Filleted Accounts Cover |  |

|  |  |  |  |  | Registered number |
|  |  |  |  |  | 05905488 |
| Nutan Pharmacy Limited |
| Filleted Accounts |
| 31 March 2025 |

Nutan Pharmacy Limited Balance Sheet Registrar |  |

at | 31 March 2025 |  |  |  |  |  |  |  |
Company No. | 05905488 |  |  |  |  |  |  |  |
|  |  |  |  | Notes |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  | £ |  |  |  | £
Fixed assets |  |  |  |  |  |  |  |
| Intangible assets |  | 4 |  | - |  |  |  | -
| Tangible assets |  | 5 |  | 47,223 |  |  |  | 53,466
| Investments |  | 6 |  | 100 |  |  |  | 100
|  |  |  |  |  |  | 47,323 |  |  |  | 53,566
Current assets |  |  |  |  |  |  |  |
| Stocks |  | 7 | 86,310 |  |  | 85,903 |  |
| Debtors |  | 8 | 299,269 |  |  | 268,794 |  |
| Cash at bank and in hand |  |  | 21,095 |  |  | 64,700 |  |
|  |  |  |  |  | 406,674 |  |  | 419,397 |  |
Creditors: Amount falling due within one year | 9 | (348,149) | () |  | (395,759) |  | ()
Net current assets |  |  |  | 58,525 |  |  |  | 23,638
Total assets less current liabilities |  |  |  | 105,848 |  |  |  | 77,204
Net assets |  |  |  | 105,848 |  |  |  | 77,204
Capital and reserves |  |  |  |  |  |  |  |
| Called up share capital |  |  |  | 100 |  |  |  | 100
| Profit and loss account |  | 10 |  | 105,748 |  |  |  | 77,104
Total equity |  |  |  | 105,848 |  |  |  | 77,204
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 11 December 2025 and signed on its behalf by: |  |
M. Patel |  |  |  |  |  |  |  |
Director |  |  |  |  |  |  |  |
11 December 2025 |  |  |  |  |  |  |  |  |

Nutan Pharmacy Limited Notes to the Accounts Registrar |  |

for the year ended 31 March 2025 |  |  |  |  |  |  |  |

1 | General information |  |
| Nutan Pharmacy Limited is a private company limited by shares and incorporated in England and Wales.
| Its registered number is: 05905488 |  |  |  |  |  |
| Its registered office is: |  |  |  |  |  |  |  |  |  |
| Bank Chambers |  |  |  |  |  |  |  |  |  |
| 1 3 Woodford Avenue |  |  |  |  |  |  |  |  |  |
| Gants Hill Ilford |  |  |  |  |  |  |  |  |  |
| Essex |  |  |  |  |  |  |  |  |  |
| IG2 6UF |  |  |  |  |  |
| The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

2 | Accounting policies |  |  |  |  |  |  |  |

| Turnover |  |  |  |  |  |  |  |
| Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances. Revenue from the sale of goods is recognised when all the following conditions are satisfied: • the Company has transferred to the buyer the significant risks and rewards of ownership of the goods; • the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; • the amount of revenue can be measured reliably; • it is probable that the economic benefits associated with the transaction will flow to the Company; and • the costs incurred or to be incurred in respect of the transaction can be measured reliably. Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.

| Tangible fixed assets and depreciation |  |  |  |  |  |  |  |
| Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses. At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
| Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
|  | Plant and machinery |  | 15% reducing balanc |  |  |  |  |  |

3 | Employees |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | Number |  |  |  | Number
|  | The average monthly number of employees (including directors) during the year was: | 6 |  |  |  | 6

4 | Intangible fixed assets |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  | Goodwill |  | Total
|  |  |  |  |  |  |  |  |  |  |  | £ |  | £
|  | Cost |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  |  |  | 980,000 |  | 980,000
|  | At 31 March 2025 |  |  |  |  |  |  |  | 980,000 |  | 980,000
|  | Amortisation and impairment |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  |  |  | 980,000 |  | 980,000
|  | At 31 March 2025 |  |  |  |  |  |  |  | 980,000 |  | 980,000
|  | Net book values |  |  |  |  |  |  |  |  |  |
|  | At 31 March 2025 |  |  |  |  |  |  |  | - |  | -
|  | At 31 March 2024 |  |  |  |  |  |  |  | - |  | -

5 | Tangible fixed assets |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | Land and buildings |  | Plant and machinery |  | Total
|  |  |  |  |  |  |  |  |  | £ |  | £ |  | £
|  | Cost or revaluation |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  | 9,823 |  | 177,443 |  | 187,266
|  | Additions |  |  |  |  |  | - |  | 357 |  | 357
|  | At 31 March 2025 |  |  |  |  |  | 9,823 |  | 177,800 |  | 187,623
|  | Depreciation |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  | - |  | 133,800 |  | 133,800
|  | Charge for the year |  |  |  |  |  | - |  | 6,600 |  | 6,600
|  | At 31 March 2025 |  |  |  |  |  | - |  | 140,400 |  | 140,400
|  | Net book values |  |  |  |  |  |  |  |  |  |
|  | At 31 March 2025 |  |  |  |  |  | 9,823 |  | 37,400 |  | 47,223
|  | At 31 March 2024 |  |  |  |  |  | 9,823 |  | 43,643 |  | 53,466

6 | Investments held as current assets |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  | Investments |  | Total
|  |  |  |  |  |  |  |  |  |  |  | £ |  | £
|  | Cost or valuation |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  |  |  | 100 |  | 100
|  | At 31 March 2025 |  |  |  |  |  |  |  | 100 |  | 100
|  | Provisions/Impairment |  |  |  |  |  |  |  |  |  |
|  | Net book values |  |  |  |  |  |  |  |  |  |
|  | At 31 March 2025 |  |  |  |  |  |  |  | 100 |  | 100
|  | At 31 March 2024 |  |  |  |  |  |  |  | 100 |  | 100

7 | Stocks |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Raw materials and consumables |  |  |  | 86,310 |  |  |  | 85,903
|  |  |  |  |  |  |  |  |  | 86,310 |  |  |  | 85,903

8 | Debtors |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Trade debtors |  |  |  | 104,217 |  |  |  | 109,157
|  | Loan to holding company |  |  |  | 193,385 |  |  |  | 122,371
|  | Corporation tax recoverable |  |  |  | - |  |  |  | 4,289
|  | Other debtors |  |  |  | 1,667 |  |  |  | 32,977
|  |  |  |  |  |  |  |  |  | 299,269 |  |  |  | 268,794

9 | Creditors: |  |  |  |  |  |  |  |
|  | amounts falling due within one year |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Trade creditors |  |  |  | 307,332 |  |  |  | 333,501
|  | Taxes and social security |  |  |  | (27,563) |  |  |  | 2,108
|  | Loans from directors |  |  |  | 56,389 |  |  |  | 49,184
|  | Other creditors |  |  |  | 11,991 |  |  |  | 10,966
|  |  |  |  |  |  |  |  |  | 348,149 |  |  |  | 395,759

10 | Reserves |  |  |  |  |  |  |  |
|  | Profit and loss account - includes all current and prior period retained profits and losses.

11 | Dividends |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Dividends for the period: |  |  |  |  |  |  |  |
|  | Dividends paid in the period |  |  |  | 24,000 |  |  |  | 24,000
|  |  |  |  |  |  |  |  |  | 24,000 |  |  |  | 24,000
|  | Dividends by type: |  |  |  |  |  |  |  |
|  | Equity dividends |  |  |  | 24,000 |  |  |  | 24,000
|  |  |  |  |  |  |  |  |  | 24,000 |  |  |  | 24,000

Nutan Pharmacy Limited 05905488 31 March 2025 01 April 2024 false 11 December 2025 BTCSoftware AP Solution 2025 12.1.02 12.1.02 86,310 85,903 299,269 268,794 21,095 64,700 406,674 419,397 348,149 395,759 true 05905488 2024-04-01 2025-03-31 05905488 2025-03-31 05905488 2024-03-31 05905488 core:WithinOneYear 2025-03-31 05905488 core:WithinOneYear 2024-03-31 05905488 core:ShareCapital 2025-03-31 05905488 core:ShareCapital 2024-03-31 05905488 core:RetainedEarningsAccumulatedLosses 2025-03-31 05905488 core:RetainedEarningsAccumulatedLosses 2024-03-31 05905488 countries:UnitedKingdom 2024-04-01 2025-03-31 05905488 bus:RegisteredOffice 2024-04-01 2025-03-31 05905488 core:PlantMachinery 2024-04-01 2025-03-31 05905488 2023-04-01 2024-03-31 05905488 core:Goodwill 2024-04-01 05905488 2024-04-01 05905488 core:Goodwill 2025-03-31 05905488 core:Goodwill 2024-03-31 05905488 core:LandBuildings 2024-04-01 05905488 core:PlantMachinery 2024-04-01 05905488 core:LandBuildings 2024-04-01 2025-03-31 05905488 core:LandBuildings 2025-03-31 05905488 core:PlantMachinery 2025-03-31 05905488 core:CostValuation 2024-04-01 05905488 core:CostValuation 2025-03-31 05905488 core:CostValuation core:UnlistedNon-exchangeTraded 2025-03-31 05905488 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 05905488 bus:AllOrdinaryShares 2024-04-01 2025-03-31 05905488 bus:SmallEntities 2024-04-01 2025-03-31 05905488 bus:FullAccounts 2024-04-01 2025-03-31 05905488 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 05905488 bus:Director2 2024-04-01 2025-03-31 05905488 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure